BXI.TO Key Stats
|Revenue (Quarterly YoY Growth)|
|EPS Diluted (TTM)||-0.2881|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||-60.96M|
|Gross Profit Margin (Quarterly)||-246.0%|
|Profit Margin (Quarterly)||-76687%|
|Dividend Yield (TTM)||0.00%|
|Payout Ratio (TTM) Pro||Go Pro|
BXI.TO Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Bioexx Specialty Proteins is down 84.62% over the last year vs and S&P 500 Total Return up 22.52%.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for BXI.TO
Pro Strategies Featuring BXI.TO
Did Bioexx Specialty Proteins make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: Canada
- Headquarters State/Province: Ontario
- Incorporation Country: Canada
- Incorporation State/Province: N/A
- Current Fiscal Year End: December 31, 2014
Bioexx Specialty Proteins, Inc. is involved in the development and commercialization of processing technologies, for use in the extracting various active ingredients from organic and inorganic materials.